{{item.type}}
{{item.title}}
{{item.meta}}
{{item.summary}}
Home Validation
What we have proved.
We label every claim by what supports it, so you can judge for yourself.
Validation status: GemChem
| Product | Result |
|---|---|
| Cellulose-binding streptavidin | 75% reduction in antibody requirements versus passive adsorption, with no reduction in test line signal strength. |
| Cellulose-binding streptavidin | Performance equivalent to the commercial incumbent streptavidin on the lateral flow test line. |
| Cellulose-binding streptavidin | Thoroughly tested in the lateral flow format in urine. |
| Gold-binding streptavidin | Oriented immobilization of both biotinylated antibody and biotinylated antigen on gold SPR sensor chips. |
| Gold-binding streptavidin | Used in Gemina’s CE-marked COVID-19 rapid antigen test, manufactured at scale under ISO 13485, with more than 4 years of real-time shelf stability. |
| Gold-binding streptavidin | Thoroughly tested in the lateral flow format in saliva and nasal fluid. |
| Silica-binding streptavidin | Up to 4x more biotin-HRP capture than commercial streptavidin-coated glass microbeads. |
Validation status: GemGold
| Product | Result |
|---|---|
| GemGold | Particle size uniformity of 2% CV on average. |
| GemGold | Up to 3x brighter signal than major commercial incumbents. |
Resources
Side-by-side studies
Comparative studies of GemChem binders and GemGold against standard methods are under way. Results will be posted here as they are cleared for release.
Error: Enter a valid email address.
Thank you. We’ll email you when results are posted.